The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

Key market opportunities in the shingles vaccine sector include rising elderly populations; expanding healthcare ...

Backed by fresh European financing, BioNTech’s Kigali facility is emerging as the cornerstone of Africa’s mRNA vaccine ...

Scientists have developed an experimental mRNA vaccine that, when combined with existing immunotherapy drugs, could 'teach' the immune system to recog ...

The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...

The official opening will be headlined by Dr Nomalungelo Gina, Deputy Minister of Science, Technology and Innovation, who ...

ATLANTA — Moderna’s respiratory syncytial virus vaccine is safe and effective for adults who have received a solid organ ...

CastleVax, a clinical-stage biotechnology company developing intranasal vaccines using its attenuated Newcastle Disease Virus (NDV)-based vaccine platform, announced today that the first participant ...

Researchers found that lung and skin cancer patients who got COVID-19 vaccines reported significantly increased survival ...

Yale researchers have developed a new vaccine that does double duty against a rare and aggressive skin cancer by targeting ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...

Under the bright lights of Durban’s convention centre, amid applause from scientists and policymakers gathered for the 4th ...